Transactions: Other
Filter
Advisory assignment for the Swedish Central Bank (SE) — Amount not disclosed.
Vendor and cash placing for Axis-Shield (UK/NO) — NOK 342 million
Convertible rights issue in Elekta (SE) — SEK 467 million
Licensing agreement for OXiGENE, Inc. (SE/US) — USD 70 million
Option program in Biovitrum (SE)
Option program in Biacore (SE)
Option program in BioInvent International AB (SE)
Option program in Karo Bio (SE)
Option program in Q-Med AB (SE)
Simplified procedure directed to 102,000 shareholders
Secondary listing on Stockholm Stock Exchange of PA Resources (SE)
- Föregående
- 1
- …
- 4
- 5
- 6
- Nästa